申请人:AC IMMUNE SA
公开号:WO2017009454A1
公开(公告)日:2017-01-19
The present invention relates to novel compounds that can be employed in the selective Tau detection of disorders and abnormalities associated with Tau aggregates such as Alzheimer's disease and other tauopathies using Positron Emission Tomography (PET) Imaging.